Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,633,070 | 8,683,947 | 11,797,590 | 11,657,940 | 10,729,790 |
| Marketable Securities | 5,500,646 | 8,148,117 | 5,183,721 | 4,276,525 | 4,134,882 |
| Receivables | 706,102 | 1,105,151 | 906,599 | 1,632,418 | 1,071,409 |
| Inventories | 121,488 | 125,246 | 263,821 | 261,891 | 268,010 |
| Other current assets | 217,114 | 205,799 | 352,779 | 253,936 | 257,369 |
| TOTAL | $18,178,420 | $18,268,260 | $18,504,510 | $18,082,710 | $16,461,460 |
| Non-Current Assets | |||||
| PPE Net | 1,302,304 | 1,222,930 | 1,215,305 | 1,155,407 | 1,080,996 |
| Investments And Advances | 2,668,395 | 2,889,822 | 2,894,196 | 2,843,449 | 2,408,090 |
| Intangibles | 2,244,008 | 2,233,270 | 2,042,653 | 2,101,368 | 1,988,060 |
| Other Non-Current Assets | 272,001 | 263,617 | 288,953 | 380,065 | 377,048 |
| TOTAL | $6,486,708 | $6,609,639 | $6,441,106 | $6,480,289 | $5,854,194 |
| Total Assets | $24,665,130 | $24,877,900 | $24,945,610 | $24,563,000 | $22,315,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 66,362 | 59,059 | 62,419 | 59,485 | 58,469 |
| Accounts payable and accrued liabilities | 548,684 | 605,186 | 467,326 | 572,368 | 467,543 |
| Other current liabilities | 1,406,119 | 1,685,333 | 2,060,771 | 1,464,976 | 1,084,894 |
| TOTAL | $2,065,756 | $2,423,798 | $2,597,880 | $2,101,028 | $1,616,596 |
| Non-Current Liabilities | |||||
| Long Term Debt | 288,035 | 243,477 | 224,429 | 246,565 | 250,206 |
| Other Non-Current Liabilities | 365,516 | 364,990 | 496,899 | 1,176,067 | 463,224 |
| TOTAL | $715,466 | $703,844 | $749,616 | $1,454,986 | $759,890 |
| Total Liabilities | $2,781,221 | $3,127,642 | $3,347,496 | $3,556,014 | $2,376,485 |
| Shareholders' Equity | |||||
| Common Shares | 303,134 | 293,033 | 290,589 | 282,211 | 261,900 |
| Retained earnings | 20,400,070 | N/A | 21,352,180 | N/A | 19,681,700 |
| Other shareholders' equity | -1,701,085 | -1,654,153 | -1,734,295 | -1,679,041 | -1,520,266 |
| TOTAL | $21,883,900 | $21,750,260 | $21,598,120 | $21,006,990 | $19,939,170 |
| Total Liabilities And Equity | $24,665,121 | $24,877,902 | $24,945,616 | $24,563,004 | $22,315,655 |